Headquartered in Melville, NY, Henry Schein Inc. HSIC is a global leading provider of healthcare products and services. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein serves more than 1 million customers and has operations in 28 countries. The company entered the prestigious Standard & Poor's (S&P) 500 Index in Mar, 2015.
Currently, Henry Schein has a Zacks Rank #3 (Hold) but that could change following its impressive third-quarter 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings:The Zacks Consensus Estimate remained steady at $1.46 per share over the last 60 days. Henry Schein’s adjusted earnings per share of $1.55 beat this estimate by 6.2%.
Revenues:Henry Schein posted revenues of $2.685 billion, beating the Zacks Consensus Estimate for revenues of $2.677 billion.
Key Stats: Revenues derived from Henry Schein's Dental segment dropped 2.5% year over year to $1.266 billion, while Animal Health segment recorded sales of $732.5 million, down 3.4% compared with the prior-year quarter. Revenues from Medical segment increased 24.3% year over year to $597.2 million, while sales from Technology and Value-added services segment climbed 3% to $89.7 million.
Major Factors: Management was upbeat about the third-quarter's results which reflected accelerated growth in adjusted EPS as well as in global sales despite the continued negative impact of the strength of the U.S. dollar. On virtue of its long-standing strategy of organic growth complemented by strategic acquisitions, Henry Schein gained market share on an overall basis during the quarter, both in North America and overseas.
Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this Henry Schein earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment